Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237315 · ClinicalTrials.gov registry record
Longitudinal Study of Urea Cycle Disorders
A clinical trial of Urea Cycle Disorders and Brain Diseases, Metabolic, Inborn, sponsored by Andrea Gropman.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 15
- Study locations
NCT00237315 is a study of Urea Cycle Disorders and Brain Diseases, Metabolic, Inborn that is actively recruiting participants, run by Andrea Gropman. The registered enrollment target is 1,500 participants, above the 22-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (6718% higher). The trial reports 15 study locations across 13 states.
The verdict
NCT00237315, a study of Urea Cycle Disorders and Brain Diseases, Metabolic, Inborn, is actively recruiting participants, sponsored by Andrea Gropman.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 15
- Study locations
Study Summary
Urea cycle disorders (UCD) are a group of rare inherited metabolism disorders. Infants and children with UCD commonly experience episodes of vomiting, lethargy, and coma. The purpose of this study is to perform a long-term analysis of a large group of individuals with various UCDs. The study will focus on the natural history, disease progression, treatment, and outcome of individuals with UCD.
Conditions Studied
Study Locations (15)
California
- University of California, Los Angeles - Los Angeles
- Stanford University Medical Center - Stanford
Other
- University of Heidelberg - Heidelberg
- University Children's Hospital - Zurich
Colorado
- Children's Hospital Colorado - Aurora
District of Columbia
- Children's National Medical Center - Washington D.C.
Massachusetts
- Children's Hospital Boston (UCDC New England Center) - Boston
Minnesota
- University of Minnesota - Minneapolis
New York
- Icahn School of Medicine at Mount Sinai - New York
Ohio
- Case Western Medical College - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2006-02 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00237315
The ClinicalTrials.gov registry entry for NCT00237315 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 22-participant average among 4 other Urea Cycle Disorders trials with a reported enrollment target (6718% higher). The listed sponsor is Andrea Gropman, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Urea Cycle Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT00237315 reports 15 study locations spanning 13 distinct geographic areas - top geographies include California, Other, Colorado.
Frequently Asked Questions
What is clinical trial NCT00237315 about?
NCT00237315 is a clinical study titled "Longitudinal Study of Urea Cycle Disorders". Urea cycle disorders (UCD) are a group of rare inherited metabolism disorders. Infants and children with UCD commonly experience episodes of vomiting, lethargy, and coma. The purpose of this study is to perform a long-term analysis of a large group of individuals with various UCDs. The study will fo...
What is the current status of trial NCT00237315?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2006-02. Estimated completion is 2026-07.
What conditions does trial NCT00237315 study?
This clinical trial studies the following conditions: Urea Cycle Disorders, Brain Diseases, Metabolic, Inborn, Amino Acid Metabolism, Inborn Errors.
Who is sponsoring clinical trial NCT00237315?
This trial is sponsored by Andrea Gropman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00237315 being conducted?
This trial has 15 study locations across California, Colorado, District of Columbia, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urea Cycle Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
RECRUITING
-
Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders
COMPLETED · Phase 2
-
Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants
COMPLETED · Phase 2
-
Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.